skip to content
Primary navigation


DrugXhance™ (fluticasone propionate nasal spray) [OptiNose US, Inc.]

April 2019

Therapeutic Area - Nasal polyps

Approval criteria

  • Patient must be at least 18 years old AND
  • Patient must have a diagnosis of nasal polyps AND
  • Xhance is prescribed by, or in consultation with, an ENT specialist AND
  • Patient must have an adherent and adequate trial and failure of at least 2 different preferred intranasal corticosteroids AND
  • Patient attests that instructions for self-administration of Xhance have been provided and understood

Quantity limits

  • 1 bottle per 30 days


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top